nodes	percent_of_prediction	percent_of_DWPC	metapath
Flupirtine—ADRA2A—attention deficit hyperactivity disorder	0.914	1	CbGaD
Flupirtine—ADRA2A—Adrenaline signalling through Alpha-2 adrenergic receptor—ADRA2C—attention deficit hyperactivity disorder	0.0182	0.211	CbGpPWpGaD
Flupirtine—ADRA2A—Adrenoceptors—ADRA2C—attention deficit hyperactivity disorder	0.00755	0.0875	CbGpPWpGaD
Flupirtine—ADRA2A—Adrenaline,noradrenaline inhibits insulin secretion—ADRA2C—attention deficit hyperactivity disorder	0.00305	0.0353	CbGpPWpGaD
Flupirtine—ADRA2A—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.00267	0.0309	CbGpPWpGaD
Flupirtine—ADRA2A—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.00262	0.0303	CbGpPWpGaD
Flupirtine—ADRA2A—Platelet Aggregation (Plug Formation)—ADRA2C—attention deficit hyperactivity disorder	0.00244	0.0282	CbGpPWpGaD
Flupirtine—ADRA2A—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.00224	0.026	CbGpPWpGaD
Flupirtine—ADRA2A—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0022	0.0255	CbGpPWpGaD
Flupirtine—ADRA2A—Adrenaline,noradrenaline inhibits insulin secretion—CACNB2—attention deficit hyperactivity disorder	0.0021	0.0244	CbGpPWpGaD
Flupirtine—ADRA2A—G alpha (z) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00208	0.0241	CbGpPWpGaD
Flupirtine—ADRA2A—Adrenaline,noradrenaline inhibits insulin secretion—CACNA1C—attention deficit hyperactivity disorder	0.00192	0.0223	CbGpPWpGaD
Flupirtine—ADRA2A—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.00158	0.0184	CbGpPWpGaD
Flupirtine—ADRA2A—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.00152	0.0177	CbGpPWpGaD
Flupirtine—ADRA2A—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.00147	0.0171	CbGpPWpGaD
Flupirtine—ADRA2A—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.00143	0.0165	CbGpPWpGaD
Flupirtine—ADRA2A—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00139	0.016	CbGpPWpGaD
Flupirtine—ADRA2A—Regulation of insulin secretion—ADRA2C—attention deficit hyperactivity disorder	0.00136	0.0157	CbGpPWpGaD
Flupirtine—ADRA2A—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00133	0.0154	CbGpPWpGaD
Flupirtine—ADRA2A—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00129	0.015	CbGpPWpGaD
Flupirtine—ADRA2A—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00124	0.0143	CbGpPWpGaD
Flupirtine—ADRA2A—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0012	0.0139	CbGpPWpGaD
Flupirtine—ADRA2A—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00116	0.0135	CbGpPWpGaD
Flupirtine—ADRA2A—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00108	0.0126	CbGpPWpGaD
Flupirtine—ADRA2A—Integration of energy metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00107	0.0123	CbGpPWpGaD
Flupirtine—ADRA2A—Regulation of insulin secretion—CACNB2—attention deficit hyperactivity disorder	0.000936	0.0108	CbGpPWpGaD
Flupirtine—ADRA2A—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.000904	0.0105	CbGpPWpGaD
Flupirtine—ADRA2A—Regulation of insulin secretion—CACNA1C—attention deficit hyperactivity disorder	0.000856	0.00992	CbGpPWpGaD
Flupirtine—ADRA2A—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.000828	0.00959	CbGpPWpGaD
Flupirtine—ADRA2A—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00076	0.0088	CbGpPWpGaD
Flupirtine—ADRA2A—Regulation of insulin secretion—SNAP25—attention deficit hyperactivity disorder	0.000748	0.00867	CbGpPWpGaD
Flupirtine—ADRA2A—Integration of energy metabolism—CACNB2—attention deficit hyperactivity disorder	0.000736	0.00852	CbGpPWpGaD
Flupirtine—ADRA2A—Integration of energy metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000673	0.0078	CbGpPWpGaD
Flupirtine—ADRA2A—Integration of energy metabolism—SNAP25—attention deficit hyperactivity disorder	0.000588	0.00681	CbGpPWpGaD
Flupirtine—ADRA2A—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.000583	0.00676	CbGpPWpGaD
Flupirtine—ADRA2A—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.000555	0.00643	CbGpPWpGaD
Flupirtine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000515	0.00597	CbGpPWpGaD
Flupirtine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000505	0.00585	CbGpPWpGaD
Flupirtine—ADRA2A—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000501	0.00581	CbGpPWpGaD
Flupirtine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000441	0.00511	CbGpPWpGaD
Flupirtine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000432	0.00501	CbGpPWpGaD
Flupirtine—ADRA2A—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.000377	0.00437	CbGpPWpGaD
Flupirtine—ADRA2A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00035	0.00405	CbGpPWpGaD
Flupirtine—ADRA2A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000336	0.00389	CbGpPWpGaD
Flupirtine—ADRA2A—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00033	0.00382	CbGpPWpGaD
Flupirtine—ADRA2A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000329	0.00382	CbGpPWpGaD
Flupirtine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000306	0.00354	CbGpPWpGaD
Flupirtine—ADRA2A—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.000301	0.00348	CbGpPWpGaD
Flupirtine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.0003	0.00347	CbGpPWpGaD
Flupirtine—ADRA2A—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000297	0.00344	CbGpPWpGaD
Flupirtine—ADRA2A—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000288	0.00334	CbGpPWpGaD
Flupirtine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000284	0.00329	CbGpPWpGaD
Flupirtine—ADRA2A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000283	0.00328	CbGpPWpGaD
Flupirtine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000275	0.00319	CbGpPWpGaD
Flupirtine—ADRA2A—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000268	0.00311	CbGpPWpGaD
Flupirtine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000267	0.0031	CbGpPWpGaD
Flupirtine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000262	0.00304	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000257	0.00298	CbGpPWpGaD
Flupirtine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000249	0.00289	CbGpPWpGaD
Flupirtine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000244	0.00282	CbGpPWpGaD
Flupirtine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000236	0.00273	CbGpPWpGaD
Flupirtine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000229	0.00265	CbGpPWpGaD
Flupirtine—ADRA2A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000228	0.00264	CbGpPWpGaD
Flupirtine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000213	0.00247	CbGpPWpGaD
Flupirtine—ADRA2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.0002	0.00231	CbGpPWpGaD
Flupirtine—ADRA2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00019	0.0022	CbGpPWpGaD
Flupirtine—ADRA2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000186	0.00216	CbGpPWpGaD
Flupirtine—ADRA2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000186	0.00215	CbGpPWpGaD
Flupirtine—ADRA2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00018	0.00208	CbGpPWpGaD
Flupirtine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000174	0.00202	CbGpPWpGaD
Flupirtine—ADRA2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000174	0.00202	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000173	0.002	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000169	0.00196	CbGpPWpGaD
Flupirtine—ADRA2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000162	0.00188	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000152	0.00176	CbGpPWpGaD
Flupirtine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000149	0.00173	CbGpPWpGaD
Flupirtine—ADRA2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000129	0.00149	CbGpPWpGaD
Flupirtine—ADRA2A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000122	0.00141	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000119	0.00137	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000117	0.00136	CbGpPWpGaD
Flupirtine—ADRA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000114	0.00132	CbGpPWpGaD
Flupirtine—ADRA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000113	0.00131	CbGpPWpGaD
Flupirtine—ADRA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000105	0.00121	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000102	0.00119	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000102	0.00118	CbGpPWpGaD
Flupirtine—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000102	0.00118	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	9.98e-05	0.00116	CbGpPWpGaD
Flupirtine—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	9.86e-05	0.00114	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	9.79e-05	0.00113	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	9.52e-05	0.0011	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	9.22e-05	0.00107	CbGpPWpGaD
Flupirtine—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	9.18e-05	0.00106	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	8.95e-05	0.00104	CbGpPWpGaD
Flupirtine—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	8.41e-05	0.000975	CbGpPWpGaD
Flupirtine—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.41e-05	0.000975	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	8.34e-05	0.000966	CbGpPWpGaD
Flupirtine—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	8.28e-05	0.000959	CbGpPWpGaD
Flupirtine—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.69e-05	0.000891	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	6.92e-05	0.000802	CbGpPWpGaD
Flupirtine—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.73e-05	0.000779	CbGpPWpGaD
Flupirtine—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.43e-05	0.000745	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.05e-05	0.000701	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.84e-05	0.000677	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.62e-05	0.000652	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.45e-05	0.000631	CbGpPWpGaD
Flupirtine—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	5.39e-05	0.000625	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.29e-05	0.000613	CbGpPWpGaD
Flupirtine—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	5.1e-05	0.000591	CbGpPWpGaD
Flupirtine—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	5.06e-05	0.000586	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.93e-05	0.000571	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.45e-05	0.0004	CbGpPWpGaD
Flupirtine—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	2.19e-05	0.000253	CbGpPWpGaD
Flupirtine—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.83e-05	0.000212	CbGpPWpGaD
